Major Galapagos investor says it will push board on company’s ‘performance’ and ‘strategic opportunities’

One of Gala­pa­gos’ biggest share­hold­ers is tak­ing a more ac­tive role in push­ing the com­pa­ny’s turn­around.

Biotech in­vest­ment firm EcoR1 Cap­i­tal, which owns 9.9% of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.